Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

NR-160 is an inhibitor of histone deacetylase 6 (HDAC6; IC50 = 0.03 µM).1 It is selective for HDAC6 over HDAC1, -2, -3, -4, and -8 (IC50s = 5.18, 2.26, 8.48, 55.4, and 14.7 µM, respectively). NR-160 is cytotoxic against a panel of seven cancer cell lines (IC50s = 22.5-51.8 µM). It enhances cytotoxicity induced by bortezomib (Item No. 10008822) in HL-60 cells, as well as cytotoxicity induced by epirubicin (Item No. 12091) or daunorubicin (Item No. 14159) in CCRF-HSB-2 T cell acute lymphoblastic leukemia cells.
WARNING This product is not for human or veterinary use.
1. Multicomponent synthesis, binding mode, and structure-